Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tasigna
Research
How Novartis' Tasigna restores dopamine in Parkinson's disease
Parkinson's patients in a trial of Novartis' Tasigna showed a boost in dopamine that may have halted the decline of motor and non-motor functions.
Arlene Weintraub
Dec 16, 2019 11:00am
Repurposing Novartis’ cancer drug Tasigna in Parkinson’s
Mar 13, 2019 11:23am
Novartis cancer drug to be tested for Parkinson’s disease
Jul 13, 2016 6:35am
